CD20I - Overview: CD20 Immunostain, Technical Component Only

Classification of lymphomas

CD103 - Overview: CD103 Immunostain, Technical Component Only

Aids in the diagnosis of hairy cell leukemia and marginal zone lymphomas

CD10 - Overview: CD10 Immunostain, Technical Component Only

Phenotyping leukemias and lymphomas

CD13 - Overview: CD13 Immunostain, Technical Component Only

Marker of myeloid lineage

CLDN4 - Overview: Claudin-4 Immunostain, Technical Component Only

Distinguishing carcinoma from mesothelioma and sarcoma

CALPN - Overview: Calponin Immunostain, Technical Component Only

Marker for myoepithelium when differentiating ductal carcinomas in situ from infiltrating breast carcinoma Characterization of tumors of smooth muscle or myoepithelial lineage

ULFA - Overview: Cryptococcus Antigen Screen, Lateral Flow Assay, Random, Urine

Aiding in the diagnosis of infection with Cryptococcus neoformans or Cryptococcus gattii This test should not be used as a test of cure. This test should not be used as a screening procedure for the general population.

199PC - Overview: Carbohydrate Antigen 19-9 (CA 19-9), Pancreatic Cyst Fluid

As an adjunct in the assessment of pancreatic cysts, when used in conjunction with carcinoembryonic antigen, amylase, imaging studies and cytology

CEAPC - Overview: Carcinoembryonic Antigen (CEA), Pancreatic Cyst Fluid

When used in conjunction with imaging studies, cytology, and other pancreatic cyst fluid tumor markers: -Distinguishing between mucinous and nonmucinous pancreatic cysts -Determining the likely type of malignant pancreatic cyst

DEXT - Overview: Dermatopathology Consultation, Wet Tissue

Histologic diagnosis and differential diagnosis of cutaneous diseases